| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.6 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |